Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-12

FDA Approved: BACLOFEN — Supplemental Application (TruPharma LLC)

View source ↗

Summary

FDA approved TruPharma LLC's supplemental application for baclofen, enabling a new generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)